JUVENILE MACULAR DEGENERATION
Clinical trials for JUVENILE MACULAR DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new JUVENILE MACULAR DEGENERATION trials appear
Sign up with your email to follow new studies for JUVENILE MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gene therapy injection aims to slow vision loss in stargardt disease
Disease control Recruiting nowThis early study tests a single injection of ACDN-01 into the eye for people with Stargardt disease or related vision loss caused by ABCA4 gene mutations. The main goal is to check safety and find the best dose. Up to 15 adults with advanced vision loss will take part. The therap…
Matched conditions: JUVENILE MACULAR DEGENERATION
Phase: PHASE1, PHASE2 • Sponsor: Ascidian Therapeutics, Inc • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Eye disease prescreening opens door to future gene therapy trials
Knowledge-focused Recruiting nowThis study is a prescreening step to find people with a specific genetic eye condition called ABCA4-related retinopathy, which includes Stargardt disease and cone-rod dystrophy. About 50 participants will undergo genetic testing and eye exams to see if they qualify for future tri…
Matched conditions: JUVENILE MACULAR DEGENERATION
Sponsor: Ascidian Therapeutics, Inc • Aim: Knowledge-focused
Last updated May 26, 2026 08:01 UTC
-
Join the fight against blindness – share your story
Knowledge-focused Recruiting nowThis registry collects health information from people with inherited retinal diseases to help researchers better understand these conditions. Participants create an online profile and can update it over time. The goal is to speed up research and connect people with clinical trial…
Matched conditions: JUVENILE MACULAR DEGENERATION
Sponsor: Foundation Fighting Blindness • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC